A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Selumetinib is well tolerated, and is active in the treatment of recurrent low-grade serous carcinoma of the ovary or peritoneum. The findings suggest that inhibitors of the MAPK pathway warrant ...

OSWEGO – The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to an innovative laboratory test — TissueCypher — that can help ...

In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in ...

Background and aims: Low grade dysplasia (LGD) is believed to predispose to colorectal cancer (CRC), and proctocolectomy has been advocated when this is identified. Between 1978 and 1990, 160 patients ...

Learn about the "pill-on-a-thread" that could replace endoscopies for half of all patients at risk of developing esophageal cancer.

Objective: Gastroesophageal reflux (GER) has emerged as a potential contributor to lung injury. This meta-analysis aimed to evaluate the association between GER and bronchopulmonary dysplasia (BPD) in ...

Diffuse low-grade gliomas (DLGG) are brain tumors of young adults. They affect the quality of life of the inflicted patients and, if untreated, they evolve into higher grade tumors where the patient's ...

Patients with low-grade dysplasia have around a one in 10 chance of developing esophageal cancer, but this risk doubles to one in five for high-grade dysplasia.

Patients with low-grade dysplasia have around a one in 10 chance of developing oesophageal cancer, but this risk doubles to one in five for high-grade dysplasia.